Pretraga

Rezultati

IGF-1R, E-cadherin, N-cadherin, and occludin gene expression and resistance to EGFR tyrosine-kinase inhibitors in patients with lung adenocarcinoma in Serbia [2024]

Jokić, Vera M.; Čavić, Milena R. ; Spasić, Jelena R. ; Marinković, Mladen S. ; Savić-Vujović, Katarina R. ; Janković, Radmila M. ; Zarić, Bojan

Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE). [2020]

Rodriguez-Abreu, Delvys; ...; Secen, Nevena M; ...; (broj, koautora 20)

Risk for HER2 3+ breast cancer brain metastases significantly diminished five years after diagnosis [2011]

Tomašević, Zorica ; Milovanovic Z; Kovac Z; Tomasevic ZM; Inic M; Gavrilovic D

Relation of methylenetetrahydrofolate reductase C677T polymorphism to chronic myeloid leukemia in Serbia. [2011]

Janković, Radmila ; Jakovljevic, K.; Čavić, Milena ; Mališić, Emina

Revealing melanoma in situ on time using DELM, for the period of last five years in former Yugoslavia [2005]

Nikolić, Dejan; Nikolić, Aleksandra ; Stanimirović, Violeta; Granić, Miroslav ; Oprić, Miroslav

Comparison of preoperative screening tools predicting postoperative complications in oncogeriatric surgical patients. [2013]

Huisman, Monique; Van, Leeuwen Barbara; Ugolini, Giampaolo; Montroni, Isacco; Stabilini, Cesare; Spiliotis, John; de, 'Liguori Carino Nicola; Farinella, Eriberto; Stanojevic, Goran Z ; Nestorovic, Milica D;

Veering, Dettie; Salawu, Abdulazeez; de, Bock GH; Audisio, Riccardo A;

Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy. [2010]

Ciuleanu, Tudor E; Samarzjia, M; Demidchik, Y; Beliakouski, V; Rancic, M; Bentsion, DL; Orlov, SV; Schaeffier, BA; De, Jager RL; Breitz, HB

Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis. [2021]

Trukhin, Dmytro; Poddubskaya, Elena; Andric, Zoran G ; Bondarenko, Igor N; Shevnia, Serhii; Zaric, Bojan ; Bellala, Ravishankar; Charoentum, Chaiyut; Perez, Luis; Bullo, Felicitas;

Garcia, Fernanda;

Young patients with breast cancer: Comparison of molecular characteristics of pregnancy associated breast cancer with non-pregnancy associated breast cancer [2015]

Tomasevic, Zorica I ; Tomasevic, Zoran M ; Kovac, Zeljko; Milovanovic, Zorka M ; Minic, Ivana Z ; Milosevic, Snezana ; Bozovic-Spasojevic, Ivana M ; Zdrale, Zdravko; Markovic, Ivan Z ; Dzodic, Radan R

Myelopreservation and reduced use of supportive care with trilaciclib in patients with small cell lung cancer. [2020]

Jared, Weiss; Jerome, Goldschmidt; Andric, Zoran G ; Konstantin, Dragnev H; Yili, Pritchett; Shannon, Morris R; Rajesh, Malik K; Davey, Daniel B